Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
amLt07Px2BPw5XwJ
